| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |